![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bone substitute materials supplemented with prolyl hydroxylase inhibitors decrease osteoclastogenesis in vitro
Publisher: John Wiley & Sons Inc
E-ISSN: 1552-4981|103|6|1198-1203
ISSN: 1552-4973
Source: Journal Of Biomedical Materials Research, Vol.103, Iss.6, 2015-08, pp. : 1198-1203
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)